Plans for distribution are now starting to take shape but seem to downplay the "human factor" and growing skepticism in the media amid debate over election returns.
Take a look . . .
KANSAS CITY, Mo. - On Monday, pharmaceutical company Pfizer announced their COVID-19 vaccine trial is showing a lot of promise . "Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine's ability to prevent COVID-19," Dr. Albert Bourla, Pfizer chairman and CEO said in a statement on the companies website.